The project
Sixera Pharma is a biopharmaceutical company based at the Karolinska Institute Science Park in Stockholm. The company was founded to develop basic research findings into treatments for skin diseases.
THE DISEASE
Netherton syndrome (NS) is a rare genetic disease leading to severe skin inflammation and allergic manifestations
SYMPTOMS & TREATMENT
NS is characterized by a combination of three clinical manifestations. The disease is often severe and can be life threatening in newborns and infants.
SCIENTIFIC RESEARCH
The founders of Sixera discovered key genes and the mechanisms regulating skin formation and barrier functions critical for the disease.
DO YOU WANT TO KNOW MORE? DON’T HESITATE TO CONTACT US!